FMR LLC 13D and 13G filings for Royalty Pharma plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-05 11:44 am Sale | 2025-09-30 | 13G | ROYALTY PHARMA PLC SHS RPRX | FMR LLC | 27,900,714 6.500% | -11,344,879 (-28.91%) | Filing |
| 2025-05-12 10:39 am Purchase | 2025-03-31 | 13G | ROYALTY PHARMA PLC SHS RPRX | FMR LLC | 39,245,593 9.100% | 12,936,266 (+49.17%) | Filing |
| 2025-02-12 09:30 am Sale | 2024-12-31 | 13G | ROYALTY PHARMA PLC SHS RPRX | FMR LLC | 26,309,327 5.900% | -5,274,599 (-16.70%) | Filing |
| 2024-02-09 09:49 am Sale | 2024-02-08 | 13G | ROYALTY PHARMA PLC SHS RPRX | FMR LLC | 31,583,926 7.099% | -12,526,439 (-28.40%) | Filing |
| 2023-02-09 12:31 pm Purchase | 2023-02-09 | 13G | ROYALTY PHARMA PLC SHS RPRX | FMR LLC | 44,110,365 9.999% | 22,030,570 (+99.78%) | Filing |
| 2022-02-09 10:24 am Sale | 2022-02-08 | 13G | ROYALTY PHARMA PLC SHS RPRX | FMR LLC | 22,079,795 5.140% | -2,862,750 (-11.48%) | Filing |